Tempus AI (NASDAQ:TEM) Stock Price Down 5.8%

Shares of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) traded down 5.8% during mid-day trading on Tuesday . The stock traded as low as $43.56 and last traded at $44.53. 342,308 shares traded hands during mid-day trading, a decline of 72% from the average session volume of 1,214,809 shares. The stock had previously closed at $47.27.

Analyst Ratings Changes

A number of research analysts have recently commented on TEM shares. Morgan Stanley assumed coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They set an "overweight" rating and a $44.00 price objective for the company. Piper Sandler assumed coverage on shares of Tempus AI in a research report on Monday, August 12th. They set a "neutral" rating and a $40.00 target price on the stock. Longbow Research assumed coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued a "buy" rating and a $48.00 price objective on the stock. Needham & Company LLC reissued a "buy" rating and set a $47.00 price objective on shares of Tempus AI in a research report on Wednesday, August 7th. Finally, Loop Capital assumed coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They issued a "buy" rating and a $48.00 price objective for the company. One investment analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $45.56.

Tempus AI Stock Performance

The stock has a 50 day moving average price of $45.76.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing analysts' consensus estimates of ($4.41) by ($2.36). The business had revenue of $165.97 million during the quarter, compared to analyst estimates of $159.10 million. On average, equities analysts expect that Tempus AI, Inc. will post -6.51 earnings per share for the current year.

Institutional Investors Weigh In On Tempus AI

A number of large investors have recently bought and sold shares of TEM. Sandia Investment Management LP acquired a new stake in shares of Tempus AI during the 2nd quarter worth about $136,000. Northwestern University acquired a new stake in Tempus AI during the second quarter worth approximately $491,000. Squarepoint Ops LLC acquired a new position in Tempus AI during the second quarter worth approximately $633,000. WINTON GROUP Ltd purchased a new position in shares of Tempus AI during the second quarter worth approximately $634,000. Finally, Scientech Research LLC acquired a new position in Tempus AI in the second quarter valued at $756,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.